About Imatinib 400 Mg
Take advantage of the sensational medical innovation that is Imatinib 400 Mg, a first-string prescription-only tablet manufactured by Cipla Ltd. Specifically formulated with Imatinib mesylate, this virtuoso anti-cancer and protein kinase inhibitor offers uncompromising efficacy for chronic myeloid leukemia and gastrointestinal stromal tumors. Each film-coated tablet delivers a precise 400 mg dose for oral cancer therapy. Redeem this opportunity to utilise an offer comprehensive enough for effective therapy, supplied in secure, boxed packing of approximately 30 strips to guarantee both convenience and safety. Store below 25C for optimal shelf life of up to two years.
Imatinib 400 Mg: Area of Application & Usage
Imatinib 400 Mg stands out as a leading therapeutic solution for chronic myeloid leukemia and gastrointestinal stromal tumors. This film-coated tablet, meant for oral cancer therapy, is designed for high-impact application in specialized oncology practices. Utilise this offer to access an advanced medication, ideal for oral administration. It promises efficiency and safety in cancer management, relying on its pharmaceutical-grade composition and targeted protein kinase inhibition for effective patient outcomes.
Imatinib 400 Mg Packaging, Delivery & Export Market
Imatinib 400 Mg is offered in a boxed/clustered packing arrangement containing approximately 30 strips, each with 10 tablets. We provide a competitive list price, ensuring value for both local and international buyers. Delivery timelines are optimized for rapid supply across main export markets, including India and beyond. Take advantage of our robust export capabilities-your assurance of consistent supply, quality packaging, and responsive global distribution tailored to medical professionals and suppliers.
FAQ's of Imatinib 400 Mg:
Q: How should I store Imatinib 400 Mg tablets for best results?
A: To ensure potency and safety, Imatinib 400 Mg tablets should be stored below 25C in a dry place, away from direct sunlight and moisture.
Q: What conditions are treated with Imatinib 400 Mg?
A: Imatinib 400 Mg is indicated for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors as prescribed by a qualified physician.
Q: When can I expect delivery after placing an order for Imatinib 400 Mg?
A: Delivery times vary based on location, but our streamlined logistics enable prompt dispatch to both local and main export markets, primarily within India and other countries.
Q: Where is Imatinib 400 Mg manufactured and supplied from?
A: This product is manufactured by Cipla Ltd and distributed globally via authorized suppliers and traders, predominantly from India.
Q: What is the process for redeeming Imatinib 400 Mg for clinical use?
A: A valid physician's prescription (Rx only) is required to redeem and utilise Imatinib 400 Mg. Ensure procurement from licensed pharmacies or authorized suppliers.
Q: How does Imatinib 400 Mg benefit cancer therapy regimens?
A: Imatinib 400 Mg, as a protein kinase inhibitor, interrupts cancer cell growth, offering a targeted anti-cancer therapy for patients diagnosed with select cancers.